Opposing actions of Stat1 and Stat6 on IL-13-induced up-regulation of early growth response-1 and platelet-derived growth factor ligands in pulmonary fibroblasts

Journal of Immunology

Volumn 177, Issue 6, 2006, Pages 4141-4148

  Ingram, Jennifer L ^a,c   Antao Menezes, Aurita ^a   Mangum, James B ^a   Lyght, Otis ^a   Lee, Patty J ^b   Elias, Jack A ^b   Bonner, James C ^a  

^a CIIT CENTERS FOR HEALTH RESEARCH   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EARLY GROWTH RESPONSE FACTOR 1; INTERLEUKIN 13; MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR A; PLATELET DERIVED GROWTH FACTOR AA; PLATELET DERIVED GROWTH FACTOR C; PLATELET DERIVED GROWTH FACTOR CC; STAT1 PROTEIN; STAT6 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ASTHMA; GENETIC TRANSCRIPTION; HUMAN; LUNG FIBROBLAST; LUNG FIBROSIS; MITOGENESIS; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA TRANSCRIPTION; TRANSCRIPTION REGULATION; TRANSGENIC MOUSE;

EID: 33748483271     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.6.4141     Document Type: Article

References (43)

1. Wills-Karp, M., J. Luyimbazi, X. Xu, B. Schofield, T. Y. Neben, C. L. Karp, and D. D. Donaldson. 1998. Interleukin-13: central mediator of allergic asthma. Science 282: 2258-2261.
2. Brewster, C. E., P. H. Howarth, R. Djukanovic, J. Wilson, S. T. Holgate, and W. R. Roche. 1990. Myofibroblasts and subepithelial fibrosis in bronchial asthma. Am. J. Respir. Cell Mol. Biol. 3: 507-511.
3. Kraft, M., C. Lewis, D. Pham, and H.W. Chu. 2001. IL-4, IL-13, and dexamethasone augment fibroblast proliferation in asthma. J. Allergy Clin. Immunol. 107: 602-606.
4. Ingram, J. L., A. B. Rice, K. Geisenhoffer, D. K. Madtes, and J. C. Bonner. 2004. IL-13 and IL-1β promote lung fibroblast growth through coordinated up-regulation of PDGF-AA and PDGF-Rα. FASEB J. 18: 1132-1134.
5. Bonner, J. C. 2004. Regulation of PDGF and its receptors in fibrotic diseases. Cytokine Growth Factor Rev. 15: 255-273.
6. Zhuo, Y., J. Zhang, M. Laboy, and J. A. Lasky. 2004. Modulation of PDGF-C and PDGF-D expression during bleomycin-induced lung fibrosis. Am. J. Physiol. 286: L182-L188.
7. Rawlings, J. S., K. M. Rosler, and D. A. Harrison. 2004. The JAK/STAT signaling pathway. J. Cell Sci. 117: 1281-1283.
8. Ehret, G. B., P. Reichenbach, U. Schindler, C. M. Horvath, S. Fritz, M. Nabholz, and P. Bucher. 2001. DNA binding specificity of different STAT proteins: comparison of in vitro specificity with natural target sites. J. Biol. Chem. 276: 6675-6688.
9. Kuperman, D., B. Schofield, M. Wills-Karp, and M. J. Grusby. 1998. Signal transducer and activator of transcription factor 6 (Stat6)-deficient mice are protected from antigen-induced airway hyperresponsiveness and mucus production. J. Exp. Med. 187: 939-948.
10. Wang, I.-M., H. Lin, S. J. Goldman, and M. Kobayashi. 2004. STAT-1 is activated by IL-4 and IL-13 in multiple cell types. Mol. Immunol. 41: 873-884.
11. Ray, R., M. Choi, Z. Zhang, G. A. Silverman, D. Askew, and A. B. Mukherjee. 2005. Uteroglobin suppresses SCCA gene expression associated with allergic asthma. J. Biol. Chem. 280: 9761-9764.
12. Yu, C.-R., R. M. Mahdi, S. Ebong, B. P. Vistica, J. Chen, Y. Guo, I. Gery, and C. E. Ewuagu. 2004. Cell proliferation and STAT6 pathways are negatively regulated in T cells by STAT1 and suppressors of cytokine signaling. J. Immunol. 173: 737-746.
13. Quarcoo, D., S. Weixler, D. Groneberg, R. Joachim, B. Ahrens, A. H. Wagner, M. Hecker, and E. Hamelmann. 2004. Inhibition of signal transducer and activator of transcription 1 attentuates allergen-induced airway inflammation and hyperreactivity. J. Allergy Clin. Immunol. 114: 288-295.
14. Walters, D. M., A. Antao-Menezes, J. L. Ingram, A. B. Rice, A. Nyska, Y. Tani, S. R. Kleeberger, and J. C. Bonner. 2005. Susceptibility of signal transducer and activator of transcription-1-deficient mice to pulmonary fibrogenesis. Am. J. Pathol. 167: 1221-1229.
15. Yan, S.-F., J. Lu, L. Xu, Y. S. Zou, J. Tongers, W. Kisiel, N. Mackman, D. J. Pinsky, and D. M. Stern. 2000. Pulmonary expression of early growth response-1: biphasic time course and effect of oxygen concentration. J. Applied Physiol. 88: 2303-2309.
16. Ning, W., C.-J. Li, N. Kaminski, C. A. Feghali-Bostwick, S. M. Alber, Y. P. Di, S. L. Otterbein, R. Song, S. Hayashi, Z. Zhou, et al. 2004. Comprehensive gene expression profiles reveal pathways related to the pathogenesis of chronic obstructive pulmonary disease. Proc. Natl. Acad. Sci. USA 101: 14895-14900.
17. Hjoberg, J., L. Le, A. Imrich, V. Subramaniam, S. I. Mathew, J. Vallone, K. J. Haley, F. H. Y. Green, S. A. Shore, and E. S. Silverman. 2004. Induction of early growth-response factor 1 by platelet-derived growth factor in human airway smooth muscle. Am. J. Physiol. 286: L817-L825.
18. Thiel, G., and G. Cibelli. 2002. Regulation of life and death by the zinc finger transcription factor Egr-1. J. Cell. Physiol. 193: 287-292.
19. Midgley, V. C., and M. Levon. 2004. Fibroblast growth factor-2 induction of platelet-derived growth factor-C chain transcription in vascular smooth muscle cells is ERK-dependent but not JNK-dependent and mediated by Egr-1. J. Biol. Chem. 279: 40289-40295.
20. Zhang, W., S. D. Yan, A. Zhu, Y. S. Zou, M. Williams, G. C. Godman, B. M. Thomashow, M. E. Ginsburg, D. M. Stern, and S.-F. Yan. 2000. Expression of Egr-1 in late stage emphysema. Am. J. Pathol. 157: 1311-1320.
21. Silverman, E. S., G. T. De Sanctis, J. Boyce, J. A. Maclean, A. Jiao, F. H. Y. Green, H. Grasemann, D. Faunce, G. Fitzmaurice, G.-P. Shi, et al. 2001. The transcription factor early growth-response factor 1 modulates tumor necrosis factor α, immunoglobulin E, and airway responsiveness in mice. Am. J. Resp. Crit. Care Med. 163: 778-785.
22. Lee, C. G., J. S. Cho, M. J. Kang, S. P. Chapoval, P. J. Lee, P. W. Noble, T. Yehualaeshet, B. Lu, R. A. Flavell, J. Milbrandt, et al. 2004. Early growth response gene 1-mediated apoptosis is essential for transforming growth factor β1-induced pulmonary fibrosis. J. Exp. Med. 200: 377-389.
23. Gaggioli, C., M. Deckert, G. Robert, P. Abbe, M. Batoz, M. U. Ehrengruber, J. P. Ortonne, R. Ballotti, and S. Tartare-Deckert. 2005. HGF induces fibronectin matrix synthesis in melanoma cells through MAP kinase-dependent signaling pathway and induction of Egr-1. Oncogene 24: 1423-1433.
24. Silverman, E., J. Du, G. T. De Sanctis, O. Radmark, B. Samuelsson, J. M. Drazen, and T. Collins. 1998. Egr-1 and Sp1 interact functionally with the 5-lipoxygenase promoter and its naturally occurring mutants. Am. J. Resp. Cell Mol. Biol. 19: 316-323.
25. Zhu, Z., R. J. Homer, Z. Wang, Q. Chen, G. P. Geba, J. Wang, Y. Zhang, and J. A. Elias. 1999. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J. Clin. Invest. 103: 779-788.
26. Calo, V., M. Migliavacca, V. Bazan, M. Macaluso, M. Buscemi, N. Gebbia, and A. Russo. 2003. STAT proteins: from normal control of cellular events to tumorigenesis. J. Cell. Physiol. 197: 157-168.
27. Battle, T. E., and D. A. Frank. 2002. The role of STATs in apoptosis. Curr. Mol. Med. 2: 381-392.
28. Shen, Y., G. Devgan, J. E. Darnell, Jr., and J. F. Bromberg. 2001. Constitutively activated Stat3 protects fibroblasts from serum withdrawal and UV-induced apoptosis and antagonizes the proapoptotic effects of activated Stat1. Proc. Natl. Acad. Sci. USA 98: 1543-1548.
29. Cho, S. J., M. J. Kang, R. J. Homer, H. R. Kang, X. Zhang, P. J. Lee, J. A. Elias, and C. G. Lee. 2006. Role of early growth response-1 (Egr-1) in IL-13-induced inflammation and remodeling. J. Biol. Chem. 281: 8161-8168.
30. Yamada, A., F. Sheikh, T. Niimi, F. J. DeMayo, A. D. Keegan, R. P. Donnelly, and S. Kimura. 2005. Induction of uteroglobin-related protein 2 (Ugrp2) gene expression by the Th2 cytokines IL-4 and IL-13. J. Immunol. 175: 5708-5715.
31. Ohmori, Y., and T. A. Hamilton. 1997. IL-4-induced STAT6 suppresses IFN-γ-stimulated STAT1-dependent transcription in mouse macrophages. J. Immunol. 159: 5474-5482.
32. Morimoto, M., N. Kume, S. Miyamoto, Y. Ueno, H. Kataoka, M. Minami, K. Hayashida, N. Hashimoto, and T. Kita. 2001. Lysophosphatidylcholine induces early growth response factor-1 expression and activates the core promoter of PDGF-A chain in vascular endothelial cells. Arterioscler. Thromb. Vasc. Biol. 21: 771-776.
33. Day, F. L., L. A. Rafty, C. N. Chesterman, and L. M. Khachigian. 1999. Angiotensin II (ATII)-inducible platelet-derived growth factor A-chain gene expression is p42/44 extracellular signal-regulated kinase-1/2 and Egr-1-dependent and mediated via the ATII type 1 but not type 2 receptor: induction by ATII antagonized by nitric oxide. J. Biol. Chem. 274: 23726-23733.
34. Elliott, J., and J. A. Johnston. 2004. SOCS: role in inflammation, allergy and homeostasis. Trends Immunol. 25: 434-440.
35. Ebong, S., C. R. Yu, D. A. Carper, A. B. Chepelinsky, and C. E. Egwuagu. 2004. Activation of STAT signaling pathways and induction of suppressors of cytokine signaling (SOCS) proteins in mammalian lens by growth factors. Invest. Ophthalmol. Vis. Sci. 45: 872-878.
36. Hebenstreit, D., P. Luft, A. Schmiedlechner, G. Regl, A. M. Frischauf, F. Aberger, A. Duschl, and J. Horejs-Hoeck. 2003. IL-4 and IL-13 induce SOCS-1 gene expression in A549 cells by three functional STAT6-binding motifs located upstream of the transcription initiation site. J. Immunol. 171: 5901-5907.
37. Lee, P. J., X. Zhang, P. Shan, B. Ma, C. G. Lee, R. J. Homer, Z. Zhu, M. Rincon, B. T. Mossman, and J. A. Elias. 2006. ERK1/2 mitogen-activated protein kinase selectively mediates IL-13-induced lung inflammation and remodeling in vivo. J. Clin. Invest. 116: 163-173.
38. Aubert, J. D., S. Hayashi, J. Hards, T. R. Bai, P. D. Pare, and J. C. Hogg. 1994. Platelet-derived growth factor and its receptor in lungs from patients with asthma and chronic airflow obstruction. Am. J. Physiol. 266(6 Pt. 1): L655-L663.
39. Lewis, C. C., H. W. Chu, J. Y. Westcott, A. Tucker, E. L. Langmack, E. R. Sutherland, and M. Kraft. 2005. Airway fibroblasts exhibit a synthetic phenotype in severe asthma. J. Allergy Clin. Immunol. 115: 534-540.
40. Wang, Y. Z., P. Zhang, A. B. Rice, and J. C. Bonner. 2000. Regulation of interleukin-1β-induced platelet-derived growth factor receptor α expression in rat pulmonary myofibroblasts by p38 mitogen-activated protein kinase. J. Biol. Chem. 275: 22550-22557.
41. Bonner, J. C., A. Badgett, P. M. Lindroos, and P. G. Coin. 1996. Basic fibroblast growth factor induces expression of the PDGF receptor α on human bronchial smooth muscle cells. Am. J. Physiol. 271(6 Pt. 1): L880-L888.
42. Coin, P. G., P. M. Lindroos, G. S. Bird, A. R. Osornio-Vargas, V. L. Roggli, and J. C. Bonner. 1996. Lipopolysaccharide up-regulates platelet-derived growth factor (PDGF) α-receptor expression in rat lung myofibroblasts and enhances response to all PDGF isoforms. J. Immunol. 156: 4797-4806.
43. Leung, T.-F., G. W. K. Wong, F. W. S. Ko, C.-Y. Li, E. Yung, C. W. K. Lam, and T.-F. Fok. 2005. Analysis of growth factors and inflammatory cytokines in exhaled breath condensate from asthmatic children. Int. Arch. Allergy Immunol. 137: 66-72.